跳转至内容
Merck
CN
所有图片(1)

文件

A3480

Sigma-Aldrich

阿托西班

≥98% (HPLC)

登录查看公司和协议定价
所有图片(1)
别名:
1-(3-巯基丙酸)-2-(O-乙基-D-酪氨酸)-4-L-苏氨酸-8-L-鸟氨酸催产素, 1-脱氨基-2-d-酪氨酸-(O-乙基)-4-苏氨酸-8-鸟氨酸催产素, 醋酸阿托西班
经验公式（希尔记法）:
C43H67N11O12S2
CAS号:
90779-69-4
分子量:
994.19
MDL编号:
MFCD00672436
UNSPSC代码:
51111800
PubChem化学物质编号:
24724390
NACRES:
NA.77

质量水平

100

检测方案

≥98% (HPLC)

形式

lyophilized powder

储存条件

desiccated

颜色

white

溶解性

H2O: ≤100 mg/mL

创始人

Ferring

运输

wet ice

储存温度

−20°C

SMILES字符串

[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](Cc2ccc(OCC)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O

InChI

1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1

InChI key

VWXRQYYUEIYXCZ-OBIMUBPZSA-N

基因信息

human ... AVPR1A(552) , OXTR(5021)
rat ... Oxtr(25342)

应用

阿托西班已用于：
  • 作为催产素受体拮抗剂
  • 用于子宫肌膜细胞钙离子动员实验的Z-因子测定并作为抑制早产临产的治疗药剂
  • 抑制小鼠臂旁核催产素受体表达神经元(OxtrPBN)的活化

生化/生理作用

阿托西班可高效抑制早产子宫收缩，不会产生任何严重的心血管、肺或中枢神经系统副作用。它可用于治疗早产临产。
阿托西班是一种肽催产素受体拮抗剂。

特点和优势

该化合物由Ferring开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。

重悬

在去离子水中以不低于100 μg/mL进行重悬，然后可将其稀释成所选的水相载体。溶液可以在2-8℃下储存最长达七天。如需延长储存时间，可加入0.1％人血清白蛋白或牛血清白蛋白的载体蛋白，并按工作用量分装后冻存在−20 °C。

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Vassilis Tsatsaris et al.
Drugs, 64(4), 375-382 (2004-02-19)
Oxytocin antagonists are synthetic analogues that have the nonapeptide structure of oxytocin. They act by competing with oxytocin for receptors in the myometrium. Animal experiments and pilot clinical studies have examined several agents and, of these, atosiban has been the
Jens Lyndrup et al.
Expert opinion on investigational drugs, 16(6), 843-853 (2007-05-16)
Preterm birth is the major cause of neonatal mortality and morbidity in the developed world. The perfect tocolytic that is uniformly effective with complete fetomaternal safety does not exist. Tocolytic agents differ in cost, utero-specificity, safety, efficacy and whether they
Raed Salim et al.
Obstetrics and gynecology, 120(6), 1323-1331 (2012-11-22)
To compare the tocolytic efficacy and tolerability of nifedipine with that of atosiban among pregnant women with preterm labor. Pregnant women admitted with preterm labor and intact membranes between 24 and 33 weeks 6 days of gestation, between January 2008
Plato Mak et al.
Journal of psychopharmacology (Oxford, England), 26(4), 532-542 (2011-09-06)
Oxytocin (OT) and arginine vasopressin (AVP), in their capacities as neuromodulators, are believed to play an important role in mood control, including regulation of the anxiety response. In the present study, the contributions of oxytocin and vasopressin receptor modulation to
Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour
versus Beta-agonists, The Worldwide Atosiban and others
British Journal of Obstetrics and Gynaecology, 108(2), 133-142 (2001)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门